IMMU-140, a Novel SN-38 Antibody–Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma
Crossref DOI link: https://doi.org/10.1158/1535-7163.MCT-17-0354
Published Online: 2018-01-01
Published Print: 2018-01-01
Update policy: https://doi.org/10.1158/crossmark_policy
Cardillo, Thomas M.
Govindan, Serengulam V.
Zalath, Maria B.
Rossi, Diane L.
Wang, Yang
Chang, Chien-Hsing
Goldenberg, David M.
Funding for this research was provided by:
N/A
